StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)
Stock analysts at StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a note issued to investors on Monday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance NYSE BTX opened at $0.34 on Monday. The business’s fifty day moving average is $0.35 and its 200 […]
![StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/brooklyn-immunotherapeutics-inc-logo-1200x675.png?v=20221104084421&w=240&h=240&zc=2)